Equities

Varex Imaging Corp

  • Add to watchlist
  • Add to portfolio
  • Add an alert

Varex Imaging Corp

Actions
Health CareMedical Equipment and Services
  • Price (USD)13.00
  • Today's Change0.12 / 0.93%
  • Shares traded33.04k
  • 1 Year change+3.26%
  • Beta0.9236
Data delayed at least 15 minutes, as of Mar 04 2026 15:29 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Varex Imaging Corporation is a designer and manufacturer of X-ray imaging components, which include X-ray tubes, digital detectors and other image processing solutions that are key components of X-ray imaging systems. The Company’s segments include Medical and Industrial. Its Medical segment designs, manufactures, sells and services X-ray imaging components, including X-ray tubes, flat panel and photon-counting detectors and accessories, high-voltage connectors, image-processing software and workstations, 3D reconstruction software, computer-aided diagnostic software, collimators, automatic exposure control devices, generators, and coolers. Its Industrial segment designs, develops, manufactures, sells, and services X-ray imaging products for use in a number of applications, including security applications for cargo screening at ports and borders, baggage screening at airports, and nondestructive testing, irradiation, and inspection applications used in a number of other verticals.

  • Revenue in USD (TTM)854.40m
  • Net income in USD-67.70m
  • Incorporated2016
  • Employees2.40k
  • Location
    Varex Imaging Corp1678 S Pioneer RdSALT LAKE CITY 84104-4205United StatesUSA
  • Phone+1 (801) 972-5000
  • Fax+1 (302) 636-5454
  • Websitehttps://www.vareximaging.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
AngioDynamics, Inc.307.31m-27.71m455.04m675.00--2.60--1.48-0.6731-0.67317.474.241.102.127.02455,268.20-9.87-13.69-13.83-16.1954.5852.46-9.02-21.321.33--0.0329---3.762.0681.56---10.06--
Neuropace Inc94.86m-23.99m457.52m209.00--24.86--4.82-0.7535-0.75352.980.55640.93211.467.16515,565.20-23.57-35.71-28.36-44.3476.7773.39-25.28-60.453.94-3.580.7603--22.1416.6717.64---8.15--
Pacific Biosciences of California Inc160.01m-546.38m459.04m485.00--85.81--2.87-1.83-1.830.53340.01770.15651.965.08329,907.20-53.45-22.47-57.35-24.2933.9733.11-341.47-214.454.47-21.700.9918--3.8915.19-76.34--49.33--
Orthopediatrics Corp227.41m-45.61m468.50m562.00--1.34--2.06-1.96-1.969.7413.930.46280.51494.83404,644.10-9.28-5.87-9.97-6.4471.7374.27-20.06-16.553.52-5.960.2214--37.6523.06-80.33--4.29--
Myriad Genetics Inc824.50m-365.90m494.66m2.70k--1.34--0.600-3.95-3.958.903.940.95098.536.97305,370.40-42.20-15.51-50.95-18.0269.9369.98-44.38-23.602.26-7.790.2458---1.56---187.43------
Mesa Laboratories Inc247.54m3.73m504.75m730.00141.192.7017.562.040.64710.647144.8133.790.56783.406.28339,097.300.8564-8.811.13-9.7162.4061.981.51-25.151.451.620.4709--11.4715.4199.22--24.600.00
Beta Bionics Inc100.25m-73.20m513.50m420.00--1.78--5.12-1.95-1.952.486.480.41912.556.34238,692.90-30.60---34.34--55.40---73.02--7.96--0.00--53.94---33.68------
Orthofix Medical Inc822.31m-92.19m523.08m1.61k--1.15--0.6361-2.34-2.3420.7611.300.9431.426.08512,343.90-10.57-12.43-13.13-15.3868.8369.37-11.21-12.991.43-1.660.2803--2.8515.1326.83--7.31--
Varex Imaging Corp854.40m-67.70m539.67m2.40k--1.13--0.6316-1.63-1.6319.3411.380.70321.856.00356,000.00-5.55-0.3327-6.45-0.395534.1533.16-7.89-0.46611.872.220.4321--4.142.73-47.38---0.5159--
Cytek Biosciences Inc201.49m-66.54m570.76m702.00--1.67--2.83-0.5197-0.51971.582.660.41932.103.27287,027.10-13.85-3.42-16.32-3.8551.8456.95-33.02-8.934.42--0.0196--0.518816.76-1,005.30--22.05--
Embecta Corp1.08bn139.50m575.02m1.85k4.10--3.180.53262.372.3718.31-10.350.97572.276.35583,621.6012.6116.6916.6022.6563.1766.7412.9215.711.873.181.7913.07-3.80-0.103321.84-25.93-26.03--
Alpha Tau Medical Ltd0.00-39.97m602.82m125.00--7.77-----0.5212-0.52120.000.90990.00----0.00-40.90-34.28-44.43-36.47------------0.0735-------8.89--11.60--
Anteris Technologies Global Corp1.91m-94.14m626.17m174.00------327.33-2.54-2.540.0518-0.00220.03691.7115.9410,994.25-181.73---285.52--70.26---4,925.51--0.7263-117.66-----29.23---23.40------
Avanos Medical Inc701.20m-72.90m650.58m2.29k--0.8352--0.9278-1.58-1.5815.1016.750.62952.426.06306,602.50-6.54-5.81-7.69-6.5850.4753.66-10.40-12.671.2611.110.1144--1.95-0.383581.13--9.36--
Data as of Mar 04 2026. Currency figures normalised to Varex Imaging Corp's reporting currency: US Dollar USD

Institutional shareholders

49.92%Per cent of shares held by top holders
HolderShares% Held
Pzena Investment Management LLCas of 31 Dec 20253.99m9.52%
BlackRock Fund Advisorsas of 31 Dec 20253.22m7.68%
Allspring Global Investments LLCas of 31 Dec 20252.66m6.34%
The Vanguard Group, Inc.as of 31 Dec 20252.63m6.28%
Dimensional Fund Advisors LPas of 31 Dec 20251.68m4.01%
Cooke & Bieler LPas of 31 Dec 20251.63m3.89%
Neuberger Berman Investment Advisers LLCas of 31 Dec 20251.49m3.54%
Frontier Capital Management Co. LLCas of 31 Dec 20251.31m3.12%
LSV Asset Managementas of 31 Dec 20251.24m2.97%
Rice, Hall, James & Associates LLCas of 31 Dec 20251.08m2.58%
More ▼
Data from 31 Dec 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.